Radiology: Recent Episodes
ReachMD
Guest: Tyler J Bradshaw, PhD
In recent years, doctors have become interested in how large language models and AI technologies could potentially improve radiology overall. Even though these technologies are still in the beginning stages of being used in medicine, eventually doctors hope to show what impact they could have on patients. To learn more about these new technologies and imaging agents, join Dr. Tyler Bradshaw, Associate Professor in the Department of Radiology at the University of Wisconsin-Madison, who presented this topic at the SNMMI 2024 Annual Meeting.
Guest: Alan Bryce, MD
Lutetium-177and radium-223 have both been shown to significantly improve survival in patients with metastatic castration-resistant prostate cancer, but how do these treatment options compare? Find out with Dr. Alan Bryce, who presented a session on this exact topic at the 2024 ASCO Genitourinary Cancers Symposium.
Host: Ezra Cohen, MD, FRCPSC, FASCO
Guest: Sue S. Yom, MD, PhD
The emergence of early clinical endpoints compared to the current gold standard of overall survival may change the landscape of how clinical trials are designed as well as how patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) are managed. At the forefront of this change are unique small molecule agents that help to overcome the inhibitory influence of tumors on the apoptotic pathway. Join Drs. Ezra Cohen and Susan Yom as they focus on why utilizing early endpoints in clinical trials, and eventually the clinic, may provide therapeutic advantages compared to our current gold standard of overall survival.
Host: Jonathan D. Schoenfeld, MD, MPhil, MPH
Guest: Robert L. Ferris, MD, PhD
The treatment of LA SCCHN has remained largely unchanged for >2 decades and the standard of care, concurrent chemoradiotherapy (CRT) with high-dose cisplatin, is associated with substantial toxicity and limited efficacy. Inhibitors of apoptosis proteins (IAPs) may well change that dynamic. Join Drs. Jonathan Schoenfeld and Robert Ferris as they focus attention on this unmet need and critically evaluate how therapeutic modulation of the apoptotic pathway may improve patient outcomes.
Host: Ezra Cohen, MD
Guest: Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Guest: Deborah J. Wong, MD, PhD
Join our international multidisciplinary panel of experts in exploring revolutionary approaches to treating patients with unresectable locally advanced squamous cell carcinoma of the head and neck. The panel will address key aspects of patient management, including new and emerging therapies, the clinical significance of early endpoints used in clinical trials, and future directions in treatment.
Host: James Galvin, MD, MPH, FANA
Guest: Gloria Chiang, MD
Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Recently, Alzheimer’s Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are unique to this agent class, raising new questions and considerations across multiple medical specialties. As there is limited formal guidance on how to recognize and mange ARIA, this activity series employs experts in the fields of neurology, radiology, emergency medicine, and primary care to provide insight into how their fields are evolving to accommodate ARIA and to outline individual roles and best practices across specialties. This activity is part of a series of six distinct programs designed to introduce ARIA, detail its recognition and management in specific clinical settings, and ultimately optimize collaborative care.
This activity focuses on the role of emergency medicine clinicians in the recognition and management of ARIA. This includes an overview of how ARIA may present to the emergency department and what courses of action to treat/manage ARIA may be needed from the hospital care team.
Note that the core activity is supplemented by an
Host: James Galvin, MD, MPH, FANA
Guest: Gloria Chiang, MD
Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Guest: Charles P. Vega, MD
Recently, Alzheimer’s Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are unique to this agent class, raising new questions and considerations across multiple medical specialties. As there is limited formal guidance on how to recognize and mange ARIA, this activity series employs experts in the fields of neurology, radiology, emergency medicine, and primary care to provide insight into how their fields are evolving to accommodate ARIA and to outline individual roles and best practices across specialties. This activity is part of a series of six distinct programs designed to introduce ARIA, detail its recognition and management in specific clinical settings, and ultimately optimize collaborative care.
This activity finishes out the series by first providing an abbreviated outline of what has been addressed across activities 1-5 followed by a multidisciplinary discussion of questions and considerations that may impact the team-based execution of discussed strategies.
Host: Kevin J. Harrington, MBBS, PhD
Guest: Barbara Burtness, MD
Guest: Ari Rosenberg, MD
There is an unmet clinical need for more durable responses in many patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). Advances in delineating the anti-apoptotic signaling mechanisms are guiding the development of novel therapeutic options for these patients. Join Drs. Kevin Harrington, Barbara Burtness, and Ari Rosenberg as they discuss challenges in treating patients with LA SCCHN and focus on the latest clinical data surrounding an antagonist of inhibitor of apoptosis proteins in this patient population.
Host: Kevin J. Harrington, MBBS, PhD
Guest: Barbara Burtness, MD
Guest: Ari Rosenberg, MD
There is an unmet clinical need for more durable responses in many patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). Advances in delineating the anti-apoptotic signaling mechanisms are guiding the development of novel therapeutic options for these patients. Join Drs. Kevin Harrington, Barbara Burtness, and Ari Rosenberg as they discuss challenges in treating patients with LA SCCHN and focus on the latest clinical data surrounding an antagonist of inhibitor of apoptosis proteins in this patient population.
Host: Janani Reisenauer, MD
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Lung cancer screenings have shown to be effective in detecting lung cancer earlier. So what are the current guidelines? To discuss this question and give their own experiences with lung cancer screenings and the management of early-stage lung cancer are expert pulmonologists, Drs. Septimiu Murgu and Janani Reisenauer. Dr. Murgu is from the University of Chicago, and Dr. Reisenauer is from the Mayo Clinic.
Host: Courtney DiNardo, MD
Guest: Marina Y. Konopleva, MD, PhD
Developments over the last few years have brought dramatic changes to the treatment landscape of acute myeloid leukemia (AML). While new therapies mean more opportunities to individualize care, clinicians are also faced with new challenges and must quickly evaluate patients, order appropriate molecular tests, assess risk, and differentiate the efficacy, safety, and applicability of novel treatments and combinations. Join Drs. Courtney DiNardo and Marina Konopleva for a discussion of how to untangle the data to determine which treatment is right for each patient in the increasingly complex clinical setting of AML.
Host: Courtney DiNardo, MD
Guest: Marina Y. Konopleva, MD, PhD
Developments over the last few years have brought dramatic changes to the treatment landscape of acute myeloid leukemia (AML). While new therapies mean more opportunities to individualize care, clinicians are also faced with new challenges and must quickly evaluate patients, order appropriate molecular tests, assess risk, and differentiate the efficacy, safety, and applicability of novel treatments and combinations. Join Drs. Courtney DiNardo and Marina Konopleva for a discussion of how to untangle the data to determine which treatment is right for each patient in the increasingly complex clinical setting of AML.
Host: Ayse Tuba Kendi, MD
Guest: A. Oliver Sartor, MD
Prostate cancer–specific antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT).
In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Janani Reisenauer, MD
Guest: Colleen Channick, MD, FCCP, DAABIP
A multidisciplinary panel including a medical oncologist, a thoracic surgeon, and an interventional pulmonologist will discuss the role of lung cancer teams in their thoracic oncology practices. The panelists will review their management of patients with lung cancer during the COVID-19 pandemic, including the impact of delayed procedures and telemedicine on patient outcomes.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Andreas Rimner, MD
Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nick Kusnezov, MD
Can you balance locum tenens with a full-time career? To answer that question, Dr. Charles Turck is joined by board-certified orthopedic surgeon, Dr. Nicholas Kusnezov, to walk us through his journey from joining the military to locum tenens.
Host: Jennifer Caudle, DO
Guest: Roni Devlin, MD
As rates of burnout continue to rise in the healthcare community, how can help our female physicians combat it? Dr. Jennifer Caudle joins Infectious Disease Specialist, Dr. Roni Devlin, to discuss how we can prevent burnout for female physicians.
Host: Eric Edell, MD, FCCP
Host: Septimiu Murgu, MD, FCCP
Guest: Narjust Duma, MD
Guest: Christopher Hartley, MD
Guest: Jeffrey Mueller, DO
Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid biopsy and comprehensive genetic and PD-L1 testing in the management of advanced lung cancer. The panelists will also explore various strategies for optimizing the quantity and quality of cytology and small volume biopsy specimens.
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Nichole Tanner, MD, MS, FCCP
Guest: Fabien Maldonado, MD, FCCP
Two internationally known interventional pulmonologists will discuss current guidelines and their own experiences regarding sampling of lung lesions and mediastinal adenopathy. Specifically, the panelists will discuss the pros and cons of various diagnostic strategies and sampling techniques, including transcutaneous and bronchoscopic biopsies. This interactive webinar will offer the opportunity for learners to ask questions prior to and during the event. Learning is augmented by a few follow-up quizzes weeks after the webinar, a strategy proven to improve knowledge gain and retention.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Samantha Conroy, MD
Locum tenens can improve quality of care around the globe—especially in remote and underserved communities. To share how, Dr. Paul Doghramji joins Dr. Samantha Conroy, a family practice obstetrician to share her experiences working as a locum tenens obstetrician in underserved communities.
Host: Jennifer Caudle, DO
Guest: Maurice G. Sholas, MD, PhD
After years of serving the New Orleans community, one physician decided to pursue locum tenens work. Dr. Jennifer Caudle joins Dr. Maurice Sholas, a pediatric physical rehabilitation physician, to share his experiences with locum tenens and in New Orleans.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: John J. Russell, MD
Guest: Joseph E. Bavaria, MD
Featuring a wide range of disciplines and a new approach to comprehensive care, what do we need to know about the Aorta Center at Penn Medicine? Dr. John Russell is joined by Dr. Joseph E. Bavaria to dive into this aortic program and discuss a new approach to comprehensive care.
Host: Neilanjan Nandi, MD
Guest: Nicholas Shaheen, MD, MPH
How do we determine which of our patients with Barrett's esophagus with dysplasia are good candidates for ablation therapy, and what’s the role of the gastroenterologist in serving patients who've already received post-ablative therapy? Joining Dr. Neil Nandi to answer those and other key questions is Dr. Nicholas Shaheen, who was the primary investigator of one of the largest multicenter studies of radiofrequency ablation.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Kathryn Gallagher, MS, RN, BSN
Guest: Kate Newcomb-DeSanto, MSN, RN, MSW
What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sandy Marks
Guest: Kim Horvath, JD
Guest: Kyle Thomson, JD
With telehealth services expanding during the COVID-19 pandemic, has our access to them changed? To better understand this, Dr. Charles Turck meets with Sandy Marks, Kim Horvath, and Kyle Thomson from the AMA to explore what’s been done to provide Medicare coverage during a public health emergency and what’s on the horizon for telehealth access.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
Host: Jennifer Caudle, DO
Guest: Sarah Ali, MD
From working in a big city to taking on an assignment in a small mountain village, Dr. Sarah Ali from the Ventura County Medical Center joins Dr. Jennifer Caudle to talk about her adventures abroad with locum tenens and share key lessons she learned along the way.
Host: Jennifer Caudle, DO
Guest: Cheryl Campos, DNP, RN-BC, CEN, CPHQ
Difficult IV access (DIVA) is a term used to describe patients who require multiple attempts to cannulate a vein. And since the prevalence of DIVA can be as high as 59 percent, Dr. Jennifer Caudle speaks with Dr. Cheryl Campos about how we can better identify high-risk patients, how we can manage DIVA patients, and more.
Host: John J. Russell, MD
Guest: Randy C. Miles, MD, MPH
Are enlarged lymph nodes caught on CT scans following mRNA vaccination cause for concern? Or is it just a case of incidentaloma? Joining Dr. John Russell to answer those and other key questions regarding the link between COVID-19 vaccines and abnormal mammogram findings is Dr. Randy C. Miles.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Mojgan Saber, MD
Can Locum Tenens be an option for healthcare professionals just completing their residency? Dr. Paul Doghramji is joined by Dr. Mojgan Saber to share her own experience as well as tips and tricks for residents looking at Locum Tenens right after residency.
Host: Charles P. Vega, MD
Guest: Lionel Phillips, MBA
Learn why diversity in clinical trials is so important to community health. Two experts discuss the key role that trusted messengers play in enrollment, why it is critical to break the cycle of medical mistrust, and the downstream effect of a lack of diversity in clinical trials.
Host: Charles P. Vega, MD
Guest: Sateria Venable
Regional healthcare disparities are biases that are based on where people live. Are your patients’ treatment options being impacted and limited by their geographical location? Join us as our two experts discuss how to support broader policy issues and highlight the importance of diagnostic algorithms that have been developed with diverse input. These steps may be of value in your clinical practice to ensure all patients have equal access to care regardless of their epidemiologic, socioeconomic, or insurance circumstances.
Host: Charles P. Vega, MD
Guest: Candice Taylor Lucas, MD, MPH, FAAP
What is cultural humility, and how can it be incorporated into clinical practice? How does your patient's culture impact their health behaviors, and why does your culture matter?
Listen in as two leading experts navigate concerns surrounding cultural humility and emphasize the importance of empathy, awareness, and advocacy. Discover ways to integrate small but important changes into your clinical practice to help bridge communication gaps and enable your patients to thrive.
Host: Charles P. Vega, MD
Guest: Robert O. Roswell, MD, FACC, FACP
Diversifying our physician workforce so that it is more racially, ethnically, and geographically balanced can ultimately have a positive impact on community health. Join us as two experts discuss how pipeline programs reaching children as early as elementary school can help ensure workplace diversity. Also find out how clinicians can be advocates for their patients by helping to disentangle them from structural inequities and working towards policy changes. There’s a lot than can be done to provide more balanced care, but we need to look beyond simple fixes to the root causes of the issues. So find your bandwidth – that’s what you can do today – and discover why it’s so important to move upstream to solve the problems manifesting downstream.
Guest: Arlene B. Chapman, MD
Guest: Matthew B. Lanktree, MD, PhD
This Expert Exchange webcast aims to improve clinicians’ ability to detect and diagnose ADPKD in at-risk patients.
Host: Jennifer Caudle, DO
Guest: Fulvio Pinelli, M.D., M.Sc.
For patients who’ve undergone an emergency cardiac procedure, the transition from emergency room to doctor’s office may be challenging. What can we do to bridge those vascular access gaps beyond the emergency setting? Dr. Jennifer Caudle is joined by Dr. Fulvio Pinelli, the director of the Vascular Access Center at the Careggi University Hospital in Florence Italy, to share some strategies for maintaining continuity of care.
Guest: Jimmy T. Lee, MD
Guest: Arlene B. Chapman, MD
This Expert Exchange webcast aims to better define the importance radiological imaging plays in the management of patients with autosomal dominant polycystic kidney disease (ADPKD).
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nadia N. Laack, MD
As survival for patients with pediatric brain tumors improves, reducing the long-term effects of cancer treatment is increasingly important. Fortunately, proton radiotherapy along with several other advancements are helping us achieve that goal. Here to share the latest treatments for pediatric patients with brain tumors with Dr. Charles Turck is pediatric oncology physician Dr. Nadia Laack.
For more information about referring a patient to Mayo Clinic, please visit mayoclinic.org and for continuing medical education opportunities visit ce.mayo.edu.
Host: Paul Doghramji, MD
Guest: Nadine Nakazawa, RN, BS
How does the patient-centric experience model for vascular access care differ from what we're used to doing, and what does it actually look like in practice? Joining Dr. Paul Doghramji to share what we need to know about the development and goals of patient-centered vascular access care is Ms. Nadine Nakazawa, a vascular access nurse specialist at Stanford Health Care.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Rajeev Attam, MD
Pancreatic cysts may be detected in up to 50 percent of patients undergoing intraabdominal MR imaging. But not all of them are malignant, so how can we determine which patients need further testing, monitoring, and perhaps even surgery? Joining Dr. Peter Buch to answer that and other questions is gastroenterologist Dr. Rajeev Attam.
Host: Jennifer Caudle, DO
Guest: Kelly Cawcutt, MD
How has the COVID-19 pandemic changed vascular access paradigms in the intensive care unit? Joining Dr. Jennifer Caudle to share her story and lessons learned from the pandemic is Dr. Kelly Cawcutt, an Assistant Professor in the Department of Internal Medicine and the Associate Medical Director of Infection Control and Epidemiology at the University of Nebraska Medical Center.
Guest: Manisha Bahl, MD
What’s recent research saying about the use of tomosynthesis versus conventional 2D digital mammography to screen for breast cancer? Find out with Dr. Manisha Bahl, a breast imaging radiologist and Assistant Professor of Radiology at Harvard Medical Center.
Host: Jacob Sands, MD
Guest: Aaron S. Mansfield, MD
There are different treatment options available for early-stage mesothelioma, and there seem to be differences in standard practice from one center to the next. Joining Dr. Jacob Sands to share how he approaches the treatment of early-stage mesothelioma using the latest options is Dr. Aaron Mansfield, an Associate Professor of Oncology and Co-Director of Precision Cancer Therapeutics at Mayo Clinic in Rochester.
Host: Jacob Sands, MD
Guest: Aaron S. Mansfield, MD
Mesothelioma is a cancer with limited treatment options, so how can we manage it in the first and second-line settings and beyond? Here with Dr. Jacob Sands to walk us through the various treatment approaches to mesothelioma is Dr. Aaron Mansfield, Associate Professor of Oncology and Co-Director of Precision Cancer Therapeutics at Mayo Clinic in Rochester.
Host: Hector O. Chapa, MD, FACOG
Guest: Andrew Little, DO
When vascular access is compromised, intraosseous access, or IO access, can help prevent fatal consequences. What do we need to know about implementing and managing this type of device? Dr. Hector Chapa is joined by Dr. Andy Little, the Associate Program Director for AdventHealth Orlando Emergency Medicine Residency, to share some insight on IO vascular access.
Guest: Gregory J Kubicek, MD
When caring for patients who are at greater risk of complications from COVID-19, what extra precautions are needed to help keep them safe and healthy? That’s what staff radiation oncologist Dr. Gregory Kubicek from the MD Anderson Cooper Cancer Center shares with us.
Published June 23, 2020
Guest: Bret Nelson, MD
When it comes to using ultrasound at the point of care in the setting of COVID-19, what do we need to keep in mind? Here to share his five key considerations is Dr. Bret Nelson, Professor of Emergency Medicine and the Chief of the Emergency Medicine Ultrasound Division at Mount Sinai Hospital.
Published June 5, 2020
Host: Matt Birnholz, MD
Guest: Wes Ely, MD, MPH
After surviving a critical illness, many patients look forward to their lives returning to normal, but unfortunately, that’s not always possible.
To uncover the far-reaching impacts of delirium, Dr. Matt Birnholz is joined by Dr. Wes Ely, Professor of Medicine and Co-Director of the Center for Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University’s School of Medicine which focuses on improving the lives and care of patients in the intensive care unit to ensure both physical and cognitive rehabilitation.
Host: Shira Johnson, MD
Guest: Ronald DeMatteo, MD, FACS
A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan.
Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.
The FDA announced that it is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (or MRI) concerning gadolinium remaining in patients’ bodies, including the brain, for months to years after receiving these drugs.
Report side effects involving GBCAs to FDA’s MedWatch program at www.fda.gov/medwatch.
A link to the full communication detailing specific information for health care professionals and a list of FDA approved GBCAs can be found at www.fda.gov/DrugSafety.
Released 12/19/2017
Host: Brian P. McDonough, MD, FAAFP
Vegetative state is commonly defined as "wakefulness with awareness." Patients with a vegetative state diagnosis will show only reflex behavior, are not able to follow commands and are unable to communicate. This barrier in the inability for patients to communicate can make it difficult for doctors to measure their level of consciousness. In fact, some patients who are believed to be in a completely vegetative state may be more aware of what's going on than people realize.
Host Brian McDonough joins Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging at the Brain and Mind Institute at Western University. They talk about how the use of MRI technology is aiding doctors in measuring the level of consciousness in patients under vegetative states.
Host: Brian P. McDonough, MD, FAAFP
Over one million amputees suffer from phantom limb pain, a debilitating condition made all the more complex to treat due to the root question "How do I treat pain arising from a limb that no longer exists?" But new understandings of the pathophysiology behind this disease have led to more meaningful interventions, enabling better counseling strategies for primary care physicians.
Dr. Brian McDonough speaks with Dr. J. David Prologo, Assistant Professor of Radiology at Emory Healthcare and Director of Interventional Radiology Services at Emory Johns Creek Hospital. Dr. Prologo has helped pioneer research ushering in new treatment methods, such as cryoablation, for the treatment of phantom limb pain in amputees.
Host: Barnett Mennen, MD
Guest: Deepak Sudheendra, MD, FSIR, RPVI
Host Dr. Barry Mennen joins Dr. Deepak Sudheendra, Assistant Professor of Clinical Radiology & Surgery at the Hospital of the University Of Pennsylvania Perelman School Of Medicine. Dr. Sudheendra will explain the difference between acute, subacute, and chronic deep vein thrombosis (DVT) and their complications. He will also discuss the scope of post thrombotic syndrome (PTS) and why it is so important to treat quickly and effectively.
Host: Jennifer Caudle, DO
Guest: Timothy W.I. Clark, MD
Host Dr. Jennifer Caudle welcomes Dr. Timothy Clark, Associate Professor of Clinical Radiology and the Director of Interventional Radiology at Penn Presbyterian Medical Center. Dr. Clark will review the prevalence of peripheral arterial disease (PAD) in the U.S., the central risk factors, and how PAD is properly diagnosed and managed. He will also review advanced endovascular procedures for PAD and other therapies that make a difference in patient care and outcomes.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Host Dr. Alan Brown welcomes Dr. Steven Nissen, Chairman of the Department of Cardiovascular Medicine and Professor of Medicine at the Lerner School of Medicine of the Cleveland Clinic. The two focus on some of the major developments in lipidology today, from roles of intravascular ultrasound to updates in clinical drug trials to perspectives on past and present guideline recommendations.
Host: Jennifer Caudle, DO
Guest: Scott O. Trerotola, MD, FACR, FSIR
Is there a way to predict complex removal of inferior vena cava filters, and if so, what is the success rate? Dr. Scott Trerotola adresses these and other questions in details. Dr. Trerotola is Stanley Baum Professor at the Hospital of the University of Pennsylvania, Chief of Vascular and Interventional Radiology and Vice Chair for Quality of the Department of Radiology at the University Of Pennsylvania Medical Center.
Guest: Martin R. Chavez, MD, FACOG
Host: Brian P. McDonough, MD, FAAFP
Host Dr. Brian McDonough is joined by Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital, to highlight updates in Non-Invasive Prenatal Testing.
Guest: Seth Baum, MD
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
This program reviews the guidelines for determining which patients should receive coronary CT angiography (CCTA), highlights the differences between CCTA and coronary calcium testing, and explores the overall radiation risk of serial CCTA. Dr. Alan Brown talks to guest Dr. Seth Baum, expert on electrophysiology, interventional cardiology, coronary CT angiography, and clinical lipidology, and a founding member of the Society for Cardiovascular CT.
Guest: Allen Taylor, MD
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Dr. Allen J. Taylor, director of advanced cardiac imaging at the Washington Hospital Center in Washington, DC, joins host Dr. Alan Brown to discuss the practical application and appropriateness of imaging guidlines related to screening for cardiovascular risk as well as carotid intima-media thickness.
Brought to you by:
Host: Matt Birnholz, MD
Tune in for significant summaries from the Radiological Society of North America's 96th Scientific Assembly and Annual Meeting, November 28th through December 3rd in Chicago.
Host: Jason Birnholz, MD
Host Dr. Jason Birnholz talks with experts on the conference floor from the Radiological Society of North America's 96th Scientific Assembly and Annual Meeting in Chicago. His guests include:
- Dr. Candice Aitken, radiation oncologist and assistant professor of medicine at Dartmouth Medical School
- Dr. Jacques Souquet, founder and CEO of SuperSonic Imagine
- Dr. Judy Kalinyak, chief medical officer of Naviscan
- Dr. William Denman, chief medical officer of GE Healthcare
Guest: Prediman Shah, MD
Host: Janet Wright, MD
It is apparent to most physicians that patients at high risk for having a cardiovascular event should be screened, but what about those patients who fall into the intermediate risk category (classified using the Framingham risk score)? Dr. Prediman Shah, director of the division of cardiology at Cedars-Sinai Heart Institute in Los Angeles, suggests that screening asymptomatic, intermediate-risk patients for subclinical atherosclerosis using non-invasive imaging might be beneficial. Dr. Shah also discusses the limitations of relying solely on the Framingham risk score, and recommends additional ways to classify a patient's risk for developing a cardiovascular event. What specific screening tests are best for detecting subclinical atherosclerosis? Dr. Janet Wright hosts.
Produced in Cooperation with
Host: Jay Goldstein, MD
Guest: Jonathan Leighton, MD
Guest: Moshe Rubin, MD
Obscure gastrointesinal bleeding can pose investigational challenges. What are the potential causes of obscure GI bleeding? After initial negative upper endoscopy and colonoscopy tests are performed, what new technologies can help physicians more effectively detect small bowel abnormalities? Dr. Jonathan Leighton, professor of medicine and chair of the division of gastroenterology at the Mayo Clinic in Arizona, and Dr. Moshe Rubin, director of gastroenterology and program director of the GI fellowship training program at New York Hospital Queens Medical Center and the Weill-Cornell Medical College in New York, discuss the roles of small bowel capsule endoscopy, balloon-assisted enteroscopy, spiral enteroscopy, and CT enterography in evaluating patients with obscure GI bleeding. Dr. Jay Goldstein hosts.
Tune in to hear important highlights from research findings presented at the Radiological Society of North America's 2009 Scientific Assembly and Annual Meeting, November 29th through December 4th.
Guest: Stamatia Destounis, MD
Host: Jason Birnholz, MD
These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th, 2009, in Chicago.
Host Dr. Jason Birnholz talks with Dr. Stamatia Destounis, associate clinical professor of radiology at the University of Rochester, and a practicing radiologist at the Elizabeth Wende Breast Care Center in Rochester, New York. Dr. Destounis presented a paper entitled "The Role of Ultrasound Elastography for Differentiating Benign from Malignant Breast Lesions: Can Benign Result Biopsies Be Reduced?"
Host: Jason Birnholz, MD
These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago.
Host Dr. Jason Birnholz talks with Dr. Rozemarijn Vliegenthart, from the University Medical Center Groningen in the Netherlands, who presented at the conference a paper entitled, "High Prevalence of Treatable Severe Coronary Artery Disease: Findings in a Randomized Controlled Trial in Cardiac Asymptomatic Peripheral Arterial Disease Patients." Dr. Birnholz also sits down with Dr. Asim F. Choudhri, from Johns Hopkins University in Baltimore, to talk about tele-radiology and smartphones.
Host: Jason Birnholz, MD
This program features Dr. David Cosgrove, professor of clinical ultrasound, Imperial College School of Medicine, and honorary consultant in radiology at the Hammersmith Hospital in London. He is an expert in ultrasound, known around the world, and is the author of numerous publications. He speaks with host Dr. Jason Birnholz about a new form of ultrasound imaging— elastography, or sheer wave imaging — for detecting breast cancer.
Next, Dr. Birhnolz sits down with Dr. Michelle Brown, associate professor of radiology at the University of California, San Diego. She is presenting research on detection of placenta accreta using MRI. The incidence of placenta accreta has increased ten-fold since 1950, as the incidence of the primary risk factor, cesarian section, has also increased.
These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago.
Host: Jason Birnholz, MD
Host Dr. Jason Birnholz reports from the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 6th in Chicago. In this segment, he speaks with Dr. Wendie Berg, from Johns Hopkins University, about early detection and breast cancer, and Dr. Alexis Kelekis, assistant professor of radiology at the University of Athens, about percutaneous disc decompression treatment for herniated disc.
Guest: James Metz, MD
Host: Lee Freedman, MD
Proton therapy has existed for decades, but it's only recently begun to be clinically adopted. Rather than being a stand-alone treatment, this therapy is often best used in conjunction with surgery or chemotherapy. Outside of oncology, what other conditions might proton therapy be used to treat? Join host Dr. Lee Freedman and his guest, Dr. James Metz, vice chair of the department of radiation oncology at Penn Medicine, to learn more about future directions of proton therapy.
Guest: Michelle Alonso-Basanta, MD, PhD
Host: Lee Freedman, MD
What are the limitations of conventional treatment for primary bone cancer and spinal metastasis? How can proton therapy be particularly beneficial for treating primary bone tumors, which are found more often in pediatric patients? And what role can proton therapy play for patients with spinal metastasis? Dr. Michelle Alonso-Basanta, the Helene Blum Assistant Professor in the department of radiation oncology at Penn Medicine, discusses some of the advantages of proton therapy, including precise targeting and reduced toxicity. Dr. Lee Freedman hosts.
Guest: Dushyant Sahani, MD
Host: Jason Birnholz, MD
More often, the diagnosis of causes of upper abdominal pain and specialty triage of patients as necessary has become the province of the radiologist. How do radiologists best approach diagnosis and management for these patients, and what factors underlie positive interactions between referring physician and radiologist for this common clinical problem? Host Dr. Jason Birnholz is joined by Dr. Dushyant Sahani, clinical instructor of radiology at Harvard Medical School and director of CT imaging services at Massachusetts General Hospital, to examine the radiology of upper abdominal pain and the expanding role of the radiologist.
Host: Jason Birnholz, MD
Guest: Dushyant Sahani, MD
Autoimmunity has been identified in over 100 separate diseases. Depending on the target tissues, these disorders may be systemic, localized, or perhaps somewhere in between. The characteristics of autoimmune pancreatitis represent one such example of diffuse-to-localized disorders, and is the subject of this discussion. New forms of imaging enable us to map the inflammatory components of this and other diseases, often identifying conditions that were not part of the original differential diagnosis. How does this both aid and complicate management strategies for patients? Host Dr. Jason Birnholz welcomes Dr. Dushyant Sahani, clinical instructor of radiology at Harvard Medical School and director of CT imaging services at Massachusetts General Hospital, to share insights and expertise on imaging autoimmune pancreatitis.
Guest: Alan Moody, MBBS
Host: Larry Kaskel, MD
Can three-dimensional MRI help us measure potential risks for stroke associated with an intraplaque hemorrhage? We are rapidly learning more about the significance of intraplaque hemorrhage, and its role in cardiac and cerebrovascular disease. A better look at potential trouble spots could allow for earlier detection of an impending event, even in relatively asymptomatic individuals. Dr. Alan Moody, professor in the department of medical imaging at the University of Toronto Faculty of Medicine, shares his perspective on 3D MRI as an important tool to lead us in this direction. On a related note, Dr. Moody also provides some insight on what we can do patients with an intraplaque hemorrhage who is already on a statin, aspirin or another therapy to reduce their risk of having this happen again. Dr. Larry Kaskel hosts.
Host: Janet Wright, MD
Guest: Robert Hendel, MD
We're seeing some progress in cardiac imaging toward this lofty goal, thanks, in part, to a system that combines online technology with science-based selection criteria. The system will help us track patterns of care, provide insights into variations in care across the country and ensure that patients get the test that brings the most value to their care. Host Dr. Janet Wright probes the areas where we can further develop our goals for providing the most appropriate care with Dr. Robert Hendel, clinical cardiologist at Midwest Heart Specialists, based in suburbs west of Chicago, and professor of medicine at Rush University Medical College in Chicago. Dr. Hendel also explores trends in the appropriate ordering of tests within a practice versus those referring to that same practice.
Guest: Andrea Doria, MD, PhD, MSc
Host: Jason Birnholz, MD
In 1888, William Osler wrote in the Lancet the following: "In patients with suspected acute appendicitis, one should urge towards laparotomy. The indications for surgical interference are not always clear, but in my experience I have been taught that the abdomen is much more frequently left untouched than it should be, and that an operation is too often deferred until practically useless." Clearly, diagnosis of acute appendicitis has come a long way since then. But challenges remain in selecting the safest, most timely, and cost-effective diagnostic modalities for this condition. Dr. Andrea Doria, associate professor in the department of medical imaging at the University of Toronto School of Medicine, clarifies the use of ultrasound versus CT for evaluation of acute appendicitis in children. Dr. Jason Birnholz hosts.
Guest: Scott Holland, PhD
Host: Jason Birnholz, MD
Guest: Daniel Choo, MD
Successful cochlear implantation has remarkable impact on quality of life for children with congenital and early onset hearing loss. How do clinicians best evaluate these children for likelihood of success with implants, and what are the imaging challenges when following up with these patients later on? Drs. Scott Holland and Daniel Choo from the University of Cincinnati examine new technologies on the horizon, from fMRI to near-infrared spectrophotometry, for screening and following candidates of cochlear implantation. In the process, they outline salient features of sensorineural hearing deficits and share the state-of-the-art in operative methods for implantation. Dr. Jason Birnholz hosts.
Guest: Stephanie Wilson, MD, FRCPC
Host: Jason Birnholz, MD
Many clinicians are well familiarized with standard contrast agents such as barium and iodinated compounds to enhance angiographic imaging. Ultrasound, capable of visualizing bloodflow with the use of doppler alone, is yet insufficiently sensitive to capture perfusion of organs and/or tumors at the capillary level. What special kinds of contrast enhancements are needed for ultrasound in this case? Dr. Stephanie Wilson, professor of medical imaging and obstetrics and gynecology at the University of Calgary in Alberta, Canada, discusses the science and art of using micro-bubble contrast agents, and the emergence of contrast-enhanced ultrasound (CEUS) as a safer alternative to traditional angiography. Dr. Jason Birnholz hosts.
Guest: John Byrne, MD
Host: Mark Nolan Hill, MD
Cardiac surgery is one of just a few medical specialties where before-and-after imaging is not yet standard. As surprising as this may seem, the effect on procedural outcomes is not surprising: current strategies for intraoperative graft assessment, for example, are not detecting all of the defects in the grafts we implant. How can we change this practice, and how can an innovative, hybrid catheterization lab-turned-operating room help us do this? Dr. John Byrne, professor of surgery and chair of cardiac surgery at Vanderbilt University School of Medicine, takes us inside this distinctive operating theatre and details the improvements in graft-defect detection seen by his team at Vanderbilt. Dr. Mark Nolan Hill hosts.
Guest: James B. Spies, MD
Host: Jason Birnholz, MD
It's not uncommon for women to report experiencing menstrual changes after having given birth two or more times. These changes include shorter cycles, increased cramping, and heavier bleeding, at times with clots. Such changes are hallmark signs of adenomyosis. Definitive diagnosis of adenomyosis can be made easily with MRI or ultrasound, but are there therapeutic options from interventional radiology as well? If so, can these methods replace hysterectomy? Dr. James Spies, professor of radiology at Georgetown University and chairman of the department of radiology at Georgetown University Medical Center, joins host Dr. Jason Birnholz to resolve these questions.
Host: Jason Birnholz, MD
Guest: James B. Spies, MD
Host Dr. Jason Birnholz and Dr. James Spies, professor of radiology at Georgetown University and chairman of the department of radiology at Georgetown University Medical Center, look at fibroid tumors- their incidence and treatment. They discuss the populations in which there is a high prevalence, as well as genetic factors and the basics of interventional radiology protocol.
Guest: J. Herman Kan, MD, FACR
Host: Jason Birnholz, MD
Pre-treatment MRI can eliminate unnecessary diagnostic or surgical procedures for children with suspected musculoskeletal infections. Host Dr. Jason Birnholz and Dr. J. Herman Kan, assistant professor of radiology at Vanderbilt University Medical Center, specializing in pediatric and adolescent radiology, discuss the application of MRIs and the results of his recent study which showed that a significant number of surgeries could be avoided with early MRI evaluation. Tune in to hear the valuable role MRI plays in the evaluation of musculoskeletal infection.
Guest: Sharlene Teefey, MD
Host: Beverly Hashimoto, MD
Dr. Sherry Teefey, professor of radiology at Washington University School of Medicine in St. Louis, discusses with host Dr. Beverly Hashimoto her experience in Bhutan and Uganda, teaching medical professionals how to use ultrasound and computed tomography and enhancing current techniques. Tune in to hear the challenges to providing imaging services in these countries and the future goals to introduce new modalities and improve radiological services in third world countries.
Guest: Sharlene Teefey, MD
Host: Beverly Hashimoto, MD
Ultrasound images of the musculoskeletal system provides pictures of muscles, tendons, ligaments, joints and soft tissue throughout the body. Dr. Sherry Teefey, associate professor of radiology at Washington University School of Medicine in St. Louis, discusses with host Dr. Beverly Hashimoto some of the common uses for this procedure. Dr. Teefey also discusses the application of musculoskeletal ultrasound in conjunction with aspiration or injection. Tune in to hear the benefits and limitations of diagnostic musculoskeletal ultrasound.
Guest: Jeffrey D. Cirillo, PhD
Host: Mary Leuchars, MD
Tuberculosis affects the lives of one third of the world's population. How are newly advancing optical imaging technologies poised to help clinicians achieve more accurate diagnosis and treatment for patients with this serious disease? Tune in to hear host Dr. Mary Leuchars explore with Dr. Jeffrey Cirillo, associate professor of microbial and molecular pathogenesis at the Texas A&M Health Science Center College of Medicine, the optical imaging techniques under development to directly detect TB at low levels. Dr. Cirillo explains how the light waves can be used to detect and definitely confirm tubercolosis without invasive techniques, which currently is not possible using CT scans.
Guest: Mark Hlatky, MD
Host: Janet Wright, MD
Does the patient with few cardiovascular risk factors who displays little, if any, sign of heart trouble warrant a coronary CT scan? For patients who may not be best suited for a CT scan, is the coronary calcium measurement a reasonable risk-assessment alternative? Dr. Mark Hlatky, professor of medicine and professor of health research and policy at Stanford University School of Medicine, explores a range of issues related to coronary CT angiography: how the rationale for ordering can change in the emergent setting versus the clinical scenario, its merits as a ‘triple rule-out' test, and the frequency with which patients undergoing a CT scan subsequently undergo angioplasty, bypass surgery, or another coronary procedure. Dr. Janet Wright hosts.
Host: Janet Wright, MD
Guest: Mark Hlatky, MD
Measuring precise risks in medicine can be a tricky proposition. Factoring risk into cost-benefit analyses can make the situation even less clear. In many ways, this is where we stand with coronary computed tomography angiograms: a scan can be immediately helpful in emergent circumstances, but at other points in the clinical care spectrum, the value of that scan is more difficult to estimate. Dr. Mark Hlatky, professor of medicine and professor of health research and policy at Stanford University School of Medicine, juxtaposes the medical aspects of these tests with the money we spend on them. Dr. Janet Wright hosts.
Guest: Fiona Gilbert, MD, MBChB, DMRD
Host: Jason Birnholz, MD
Dr. Fiona Gilbert, Roland Sutton Chair of Radiology at University of Aberdeen Institute of Medical Sciences, discusses her research findings that showed that the rate of breast cancer detection by two experts reading a mammogram was the same as one expert aided by a computer. Dr. Gilbert explains to host Dr. Jason Birnholz that, unlike in the United States, it is normal practice in the United Kingdom for two trained readers to examine mammograms. Tune in to hear how computer-aided detection is likely to improve breast cancer detection in those countries where a single reader is used, as well as improve efficiencies in countries that require two readers.
Guest: Rizwan Aslam, MD
Host: Jason Birnholz, MD
Guest: Michael J. Welch, PhD
Host Dr. Jason Birnholz takes you to the 2008 Radiological Society of North America (RSNA) 94th Scientific Assembly and Annual Meeting, held in Chicago November 30 through December 5. Dr. Birnholz talks with three of the meeting's key presenters. He sits down first with Dr. Michael Welch, co-director of the division of radiological sciences at Washington University's Mallinckrodt Institute of Radiology in St. Louis, Missouri, who highlights advances in nanotechnology for imaging and drug delivery. Next, Dr. David Weinreb, radiology resident at the Hospital of Saint Raphael in New Haven, Connecticut, discusses the advantages of portable CT for treating acute stroke patients in the emergency department. Finally, Dr. Rizwan Aslam, assistant clinical professor of radiology at the University of California San Francisco School of Medicine, reports on mineral density assessment with CT colonography, concurrent to colorectal cancer screening.
Host: Beverly Hashimoto, MD
Guest: Jonn Cronan, MD, FACR
Thanks to extremely sensitive ultrasound technology, thyroid nodules are being detected and treated at unprecedented rates. Host Dr. Beverly Hashimoto welcomes Dr. John Cronan, professor of diagnostic imaging at the Brown University School of Medicine and chairman of the diagnostic imaging department at Rhode Island Hospital, to discuss the phenomenon of over-treatment of thyroid nodules. Is this pattern of care helping or harming our patients?
Guest: Andrew Muir, MD
Host: Jennifer Shu, MD, FAAP
Cerebral edema is the most common cause of death among children with diabetes, occurring as a complication of diabetic ketoacidosis (DKA) in about one percent of children with Type 1 diabetes. Among our young patients, who carries the greatest risk for cerebral edema? How can we prevent, recognize and treat this complication of DKA? Dr. Andrew Muir, professor of pediatrics and chief of pediatric endocrinology at Emory University School of Medicine, talks about the timing of cerebral edema onset relative to diabetes, and potential theories that could explain the pathophysiology of the condition. What signs and symptoms should lead physicians to suspect cerebral edema, and should imaging play any role in diagnosis? Dr. Jennifer Shu hosts.
Guest: David Felson, MD, MPH
Host: Mark Nolan Hill, MD
A patient in your office describes the knee pain they have been feeling for an extended period of time. The MRI that you order on their knee reveals meniscal damage. New research is telling us that meniscal tears may be more common than we realize, and further, raises questions as to whether the meniscal tear is really the source of your patient's knee pain. Dr. David Felson, professor of medicine at the Boston University (BU) School of Medicine and professor of epidemiology at the BU School of Public Health, explains that damaged meniscal cartilage may not be directly linked to knee pain. Dr. Mark Nolan Hill hosts.
Guest: Roee Lazebnik, MD, PhD
Host: Jason Birnholz, MD
Developments in ultrasound technologies yield superior image quality. But these new technologies are also designed to maximize information density– minimizing acquisition time, decreasing analysis time, and simplifying reporting. Dr. Roee Lazebnik, a radiologist with a PhD in biomedical engineering, employed by Siemens Healthcare, explains to host Dr. Jason Birnholz how the new ultrasound imaging equipment gives greater information density by increasing the amount of clinical information derived from an image.
Guest: Vicki Noble, MD
Host: Beverly Hashimoto, MD
Dr. Vicki Noble, director of the Division of Emergency Ultrasound at Massachusetts General Hospital in Boston, discusses with host Dr. Beverly Hashimoto the importance of ultrasound in the critical care setting. In the emergency department, ultrasound can improve the physican's ability to administer appropriate treatment during the crucial "golden hour" of trauma. Dr. Noble also discusses six additional applications for ultrasound in the emergency department.
Host: Beverly Hashimoto, MD
Guest: Beryl Benacerraf, MD
More than amazing images, the utility of three dimensional ultrasound images in obstetrics is expansive, according to guest Dr. Beryl Benacerraf, director of obstetrical ultrasound at Massachusetts General Hospital. Dr. Benacerraf and host Dr. Beverly Hashimoto talk about the ability of volume imaging to capture an image of the uterus from a coronal view, a view that is critical for assessment but could not be obtained through traditional portals of entry prior to 3-D imaging. Dr. Benacerraf also illuminates the diagnostic benefits of other display modalities permitted by volume imaging, such as surface renderings and tomographic cuts.
Host: Roy Levit, MD
Dr. Richard Rosen, surgeon director for the department of ophthalmology and director of ophthalmic research in the Advanced Imaging Center at New York Eye and Ear Infirmary, joins host Dr. Roy Levit to discuss technologies and methods to examine the retina.
Guest: Brian Garra, MD
Host: Jason Birnholz, MD
Ultrasound elastography, or tissue strain imaging, can provide real-time quantitative analysis on deep tissue and small nodules that elude palpation. Dr. Brian Garra, professor and vice chair of radiology at the University of Vermont College of Medicine, discusses with host Dr. Jason Birnholz, what makes this method of imaging like “palpation on steroids.” How can elastography technology help catch disease in its earliest stages, and in some cases even make biopsy unnecessary?
Guest: Eyal Herzog, MD, FACC
Host: Jason Birnholz, MD
So small, it is called the ‘pocket ultrasound,' Dr. Eyal Herzog, director of the cardiac care unit at St. Luke's-Roosevelt Hospital Center in New York, discusses with host Dr. Jason Birnholz the results of his research on the handheld portable ultrasound unit in the cardiac care department. Dr. Herzog reports no significant differences in image quality compared to the larger, high-end machine. The portability of the handheld has the capacity to improve care by increasing the speed at which we can assess critically ill patients.
Guest: Thomas D. Wang, MD, PhD
Host: Mark DeLegge, MD
Microscopic imaging of the digestive tract moves beyond examination of tissue at subcellular levels, helping us identify molecular regions in which to probe for dysplasia. Dr. Thomas Wang, assistant professor of medicine and biomedical engineering at the University of Michigan Medical School, details this 'biopsy inside the body' with host Dr. Mark DeLegge. How could this technology shape the future of GI practice? How does this differ from chromoendoscopy, autofluorescence, and other current technologies?
Guest: Mani Vannan, MBBS
Host: Jason Birnholz, MD
Dr. Mani Vannan, professor of clinical internal medicine at the Ohio State University College of Medicine, reports how the latest ultrasound technology has dramatically improved echocardiography by enabling the acquisition of a full volume image in one heartbeat. In addition, the new technology of the ultrasound equipment produces meaningful output information from the image. Dr. Vannan also explains to host Dr. Jason Birnholz the practical implications these enhancements have in terms of diagnosing cardiovascular conditions and enhancing workflow productivity.
Guest: Wendie Berg, MD, PhD
Host: Lisa Mazzullo, MD
The number of women affected by breast cancer every year is staggering: almost 180,000 new cases and upwards of 40,000 deaths. Researchers are focused on finding novel ways to detect a malignancy before it spreads-to the lymph nodes and beyond. Dr. Wendie Berg, a breast imaging radiologist associated with the Johns Hopkins University School of Medicine, talks with host Dr. Lisa Mazzullo about her latest work: studying the use of ultrasound, in conjunction with mammography, to detect breast cancer in high-risk women.
Host: Beverly Hashimoto, MD
Guest: Dawna Kramer, MD
Although most abnormal vaginal bleeding is caused by hormone imbalance, it can be indicative of polyps, myomas, and cancers of the cervix and endometrium. Dr. Dawna Kramer, a radiologist within the department of radiology, ultrasound section at the Virginia Mason Medical Center in Seattle, discusses with host Dr. Beverly Hashimoto several ultrasound techniques, including sonohysterography, for determining the cause of post- and pre-menopausal vaginal bleeding.
Guest: Dawna Kramer, MD
Host: Beverly Hashimoto, MD
Have new techniques changed the long-standing paradigm of breast cancer detection by mammogram? Dr. Dawna Kramer, radiology quality assurance officer and section head of the patient access area in the radiology department at the Virginia Mason Medical Center in Seattle, talks with host Dr. Beverly Hashimoto about the applications and inter-relationship of mammography and breast ultrasound in the diagnosis of breast masses. Dr. Kramer highlights the reasons mammography continues to account for the majority of breast mass detections. What are the benefits of digital mammogram and what is the usefulness of breast ultrasound and MRI?
Guest: Theodore Dubinsky, MD
Host: Jason Birnholz, MD
Dr. Theodore Dubinksy reviews the conventional use of ultrasound imaging to detect and diagnose thyroid nodules, including fine needle biopsies. He then explains how ultrasound elastography, a newly developed technique, to analyze the stiffness of non-palpable nodules by measuring the amount of distortion from the carotid artery, an highlights the results of this method, as well as the potential for this technique to replace fine needle aspirations as a means for diagnosing thyroid nodules. Dr. Jason Birnholz hosts.
Host: Michael Greenberg, MD
Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden death in young athletes. Joining host Dr. Michael Greenberg to discuss HCM is Dr. Martin Maron, director of the Hypertrophic Cardiomyopathy Center and co-director of cardiac MRI and CT at Tufts Medical Center. As an imaging specialist, Dr. Maron utilizes cardiac MRI and cardiac CT for the evaluation and treatment of patients. Discussing all aspects of HCM, Dr. Maron and Dr. Greenberg address this most common of all genetic cardiac diseases (occurring in 1/500 individuals), invasive and non-invasive treatment, and implications for HCM patients involved in sports.
Guest: Craig Israelite, MD
Host: Lee Freedman, MD
In surgery, we strive for less invasive procedures that still allow for the greatest precision possible. Developments in image-guided surgery are helping us meet this goal. Dr. Craig Israelite, assistant professor of orthopedic surgery at the University of Pennsylvania Health System, joins host Dr. Lee Freedman to discuss computer-assisted tools for surgery. How has the field evolved since its inception ten years ago? What are the key risks or drawbacks to consider with this technology?
Guest: John Cantwell, MD
Host: Larry Kaskel, MD
"If cost were not an issue, all athletes should have a mandatory baseline EKG and a limited echocardiogram," says our guest Dr. John Cantwell, cardiologist with Cardiology of Georgia P.C. and sports physician for Georgia Tech and the Atlanta Braves. He would even apply these standards to high school athletes. In this segment, Dr. Cantwell and host Dr. Larry Kaskel explore the causes of sudden cardiac death and discuss prevention measures in professional, collegiate and amateur athletes.
Guest: Charles Enke, MD
Host: Gary Kohn, MD
What's around the bend for radiation targeting systems? Dr. Charles Enke, professor and chair of radiation oncology at the University of Nebraska College of Medicine, speaks with host Dr. Gary Kohn about the potential of electromagnetic targeting and tracking as used in the GPS-like Calypso-guided technology. Detecting prostate motion in real-time, eliminating inter-observer variation, and providing the benefit of more precise radiation targeting are, as Dr. Enke mentions, just a few of the benefits with this new technology.
Guest: Charles Enke, MD
Host: Gary Kohn, MD
Keeping closer tabs on the intrafractional movement of the prostate during radiation therapy will continue to play an increasingly significant role in improving our overall success when treating prostate cancer. So says Dr. Charles Enke, professor and chair of radiation oncology at the University of Nebraska College of Medicine. He details the latest in prostate imaging with host Dr. Gary Kohn. How are we enhancing our command of real-time monitoring modalities?
Guest: Don Rockey, MD
Host: Jay Goldstein, MD
CT colonography has been touted as a less invasive and lower-risk alternative to traditional screening colonoscopy. When considering accuracy and test functionality, do the realities match the acclaim? Host Dr. Jay Goldstein speaks with Dr. Don Rockey, professor of internal medicine and chief of digestive and liver diseases at the University of Texas Southwestern Medical School, about the practicalities of CT colonography and its potential role in colorectal cancer screening.
Guest: Walter Stadler, MD
Host: Bruce Bloom, DDS, JD
In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years? Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forward from that early discovery to the current cutting edge uses for Avastin and other anti-angiogenics in cancer, including successes and shortcomings of this class of drugs in treating both solid tumors and blood cancers .
Guest: Melda Dolan, MD
Host: Paul Raeburn
The FDA has recently put a black box warning on ultrasound contrast agents, suggesting that they could pose risks to patients. A researcher who says the FDA had little basis for its decision is now reporting a study that finds that contrast agents are overwhelmingly safe--and that their benefits far outweigh any possible risk. Paul Raeburn hosts.
Guest: Christopher Cates, MD
Host: Mark Nolan Hill, MD
Following an interventional radiologic procedure, patients often have to lay still for 6-8 hours to enable their groin wound to properly close. Often times the patient returns to the physician because of a groin complication. Today's guest, Dr. Christopher Cates holds a patent on a new method for quickly sealing arterial puncture sites, decreasing the time it takes for the groin wound to seal and improving outcomes. Join host Mark Nolan Hill for an interesting interview.
Guest: Christopher Cates, MD
Host: Mark Nolan Hill, MD
Physicians at Emory recently developed a procedure that combines Virtual Reality with MRI to enable vascular surgeons to walk through a procedure using Virtual Realty minutes before they do the actual procudure. In this segment, join host, Dr. Mark Nolan Hill walk through the VR procedure as a surgeon would, prior to conducting the actual procedure with our guest Dr. Christopher Cates from Emory University School of Medicine.
Guest: Christopher Cates, MD
Host: Mark Nolan Hill, MD
Physicians at Emory recently developed a procedure that combines Virtual Reality with MRI to enable vascular surgeons to walk through a procedure using Virtual Realty minutes before they do the actual procudure. In this segment, join host, Dr. Mark Nolan Hill learn how this procedure was developed and how it is currently being used in practice and in training from our guest, Dr. Christopher Cates.
Guest: Clarisa Gracia, MD
Host: Lisa Mazzullo, MD
More than five percent of new cancer cases occur in women of prepubescent and childbearing age. Which of the current cancer treatments specifically influence fertility? Are prepubescent women less vulnerable to the damaging effects of therapy? Dr. Clarisa Gracia, assistant professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, joins host Dr. Lisa Mazzullo to review methods to reduce and monitor the impact of chemotherapy or radiation on fertility.
Guest: Roger Hudgins, MD
Host: Bill Rutenberg, MD
In this segment Dr. Roger Hudgins discusses many of the technologies used to pinpoint the tumors of a pediatric epileptic patient. He discusses pre and post operative imaging and interoperative imaging.
Guest: Todd Clements, MD
Host: Leslie P. Lundt, MD
Dr. Todd Clements of the Amen Clinics discusses SPECT imaging in psychiatry – what is it, when to order it, why might it be useful in treatment settings.
Guest: Joe Frascella, MD
Host: Bill Rutenberg, MD
Researchers now know that the brain is able to change from birth to death. Imaging studies of the drug addicted show proof of the changes in the brain through the addiction and again through recovery. In this segment, Dr. Joseph Frascella of NIDA explains what researcher have learned from neuro-imaging about the re-wiring of the brain.
Guest: Abbas Chamsuddin, MD
Host: Cathleen Margolin, PhD
Dr. Abbas Chamsuddin discusses the new procedure, ultrasound-assisted thrombolysis.
Host: Larry Kaskel, MD
Guest: Elizabeth Tieman, MD
Work-life balance: how many of us can say we have it, let alone come close to having it? Board-certified radiologist Dr. Betsy Tieman is one healthcare professional who can say she achieved work-life balance by leaving private practice where she was working 14 hours a day to take advantage of locum tenens work, which also enabled her to train and compete in triathlons.
Guest: David Levesque
Host: Larry Kaskel, MD
Dr. Larry Kaskel is joined by David Levesque, VP of GLobal Learning at Sonosite Inc. Mr. Levesque will discuss the many varied applications and the new and different uses of the hand-carried ultrasound.
Guest: William Pawluk, MD
Host: Laura Humphrey, PhD
In this segment, Dr. William Pawluk defines some of the primary principals regarding the use of magnetic fields for health and healing. He addresses many of the health benefits that can come from the use of electromagnetic stimulation and explains some of the ways pulse magnetic fields are applied to a patient.
Guest: William Pawluk, MD
Host: Laura Humphrey, PhD
Learn about basic concepts of magnetic fields and how they affect all living things. In this segment, Dr. William Pawluk explores general and technical information about the science of magnetic fields and their effect on biology. He also begins to talk about applications of magnetic therapy.
Guest: Mark Carvlin, PhD
Host: Larry Kaskel, MD
Medical imaging to diagnose and manage cardiovascular disease
Guest: Mark Carvlin, PhD
Host: Larry Kaskel, MD
Medical Imaging to diagnose and manage cardiovascular disease
Guest: Mark Carvlin, PhD
Host: Larry Kaskel, MD
Medical Imaging to diagnose and manage cardiovascular disease
Guest: Mark Carvlin, PhD
Host: Larry Kaskel, MD
Medical Imaging to diagnose and manage cardiovascular disease
Guest: Keith Thulborn, MD, PhD
Host: Cathleen Margolin, PhD
Keith Thulborn, M.D., Ph.D. discusses use of the 9.4 tesla MRI to better understand healthy and diseased human brains
Guest: Keith Thulborn, MD, PhD
Host: Cathleen Margolin, PhD
Keith Thulborn, M.D., Ph.D. discusses his work in designing and acquiring the most powerful MRI machine yet.
Guest: Keith Thulborn, MD, PhD
Host: Cathleen Margolin, PhD
Keith Thulborn, M.D., Ph.D. discusses how fMRI works and it's latest uses.
Guest: Kaimana MacDonald, MD
Host: Leslie P. Lundt, MD
Dr. MacDonald discusses neuroimaging of the brain, or the study of brain processes.
Guest: Joshua Fenton, MD
Host: Lee Freedman, MD
Dr. Fenton discusses the ramifications of his trial of the use of computer assistance for mammographic interpretation in terms of its impact on the use of computers for mammograms and for other radiologic procedures in the future.
Guest: Joshua Fenton, MD
Host: Lee Freedman, MD
Dr. Fenton discusses the details of his impressive trial that examined the effect of computer assistance in the interpretation of mammograms on accuracy, cost, biopsy rates and other parameters.
Guest: Joshua Fenton, MD
Host: Lee Freedman, MD
Dr. Fenton discusses the use of computer assistance in interpretation of mammography.